[Clinical characteristics and impact on prognosis of acute kidney injury in neurocritical patients in high-altitude areas].
文献摘要
Objective To investigate the incidence and severity of acute kidney injury (AKI) in neurocritical patients at high altitude and its impact on prognosis. Methods A retrospective analysis was conducted. The clinical data of adult critically ill neurological patients admitted to the critical care medicine of People's Hospital of Xizang Autonomous Region from January 1, 2022, to February 29, 2024 were enrolled. AKI was diagnosed according to the Kidney Disease: Improving Global Outcomes (KDIGO) serum creatinine criteria. The incidence, underdiagnosis rate and severity of AKI within 7 days after intensive care unit (ICU) admission were analyzed. The primary endpoint was in-hospital adverse outcome, defined as death or withdrawal of treatment during hospitalization. The secondary endpoint included persistent deterioration of renal function at discharge, length of ICU stay, total hospital stay and hospitalization costs. Univariate and multivariate Logistic regression analyses were performed to examine the relationship between AKI and adverse outcomes in patients with neurocritical illness. Results Among the 390 critically ill neurological patients at high altitude, the incidence of AKI was 21.3% (83/390), with an underdiagnosis rate of 50.6% (42/83). Among the 83 patients with AKI, 42 (50.6%) had stage 1 AKI, 21 (25.3%) stage 2, and 20 (24.1%) stage 3; moderate to severe AKI (stage 2-3) accounted for 49.4% (41/83). In addition, most AKI cases (83.1%) developed within 3 days after ICU admission. During hospitalization, 102 patients experienced adverse outcomes, including 65 deaths and 37 cases of treatment withdrawal. The prevalence of AKI was significantly higher in patients with in-hospital adverse outcome than that in patients with favorable prognosis (40.2% vs. 14.6%, P Conclusions AKI exhibits a high incidence and common underdiagnosis in patients with high-altitude critical neurological illness. It mainly occurs at the early stage of ICU admission, with a high proportion of stage 2-3 cases. AKI is an independent risk factor for in-hospital adverse outcomes in such patients, and the risk of adverse outcomes increases with the severity of AKI stage.